Emergent BioSolutions Inc.EBSNYSE
Loading
Year-over-year research & development expense growth
Percentile
P14
Within normal range
vs 5Y Ago
-4.8x
Contraction
Streak
2 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | -24.75% |
| 2024 | -36.54% |
| 2023 | -40.84% |
| 2022 | -19.94% |
| 2021 | -1.13% |
| 2020 | 5.17% |
| 2019 | 58.40% |
| 2018 | 46.61% |
| 2017 | -8.89% |
| 2016 | -10.31% |